[Federal Register Volume 67, Number 244 (Thursday, December 19, 2002)]
[Notices]
[Page 77798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-32157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Pulmonary-Allergy Drugs Advisory Committee; Cancellation

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is canceling the 
meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for 
December 20, 2002. This meeting was announced in the Federal Register 
of November 13, 2002 (67 FR 68878).

FOR FURTHER INFORMATION CONTACT: Kimberly L. Topper, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or e-mail: 
[email protected], or FDA Advisory Committee Information Line, 1-
800-741-8138 (301-443-0572 in the Washington, DC area), code 12545.

    Dated: December 16, 2002.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 02-32157 Filed 12-17-02; 3:05 pm]
BILLING CODE 4160-01-S